PGK1 and cancer: Attenuating the enzymatic activity of PGK1 by targeting its post-translational modifications (including phosphorylation, acetylation, ubiquitination, etc.)which have been shown significantly altered in cancer might reduce systemic toxicity and is an alternative approach [35, 40, 63, 64].